291 related articles for article (PubMed ID: 31695779)
1. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Human Serum Albumin-Cisplatin Complex in U87MG Xenograft Mouse Models.
Park CR; Kim HY; Song MG; Lee YS; Youn H; Chung JK; Cheon GJ; Kang KW
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114661
[TBL] [Abstract][Full Text] [Related]
3. Imaging of Indocyanine Green-Human Serum Albumin (ICG-HSA) Complex in Secreted Protein Acidic and Rich in Cysteine (SPARC)-Expressing Glioblastoma.
Jang HJ; Song MG; Park CR; Youn H; Lee YS; Cheon GJ; Kang KW
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614294
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of arginylglycylaspartic acid to human serum albumin decreases the tumor-targeting effect of albumin by hindering its secreted protein acidic and rich in cysteine-mediated accumulation in tumors.
Park CR; Song MG; Park JY; Youn H; Chung JK; Jeong JM; Lee YS; Cheon GJ; Kang KW
Am J Transl Res; 2020; 12(6):2488-2498. PubMed ID: 32655786
[TBL] [Abstract][Full Text] [Related]
5. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
[TBL] [Abstract][Full Text] [Related]
6. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
7. A near infrared light-triggered human serum albumin drug delivery system with coordination bonding of indocyanine green and cisplatin for targeting photochemistry therapy against oral squamous cell cancer.
Wang Y; Xie D; Pan J; Xia C; Fan L; Pu Y; Zhang Q; Ni YH; Wang J; Hu Q
Biomater Sci; 2019 Dec; 7(12):5270-5282. PubMed ID: 31603446
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.
McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA
Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076
[TBL] [Abstract][Full Text] [Related]
9. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA
Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716
[TBL] [Abstract][Full Text] [Related]
10. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
Desai NP; Trieu V; Hwang LY; Wu R; Soon-Shiong P; Gradishar WJ
Anticancer Drugs; 2008 Oct; 19(9):899-909. PubMed ID: 18766004
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
13. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
[TBL] [Abstract][Full Text] [Related]
14. Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.
Chlenski A; Dobratic M; Salwen HR; Applebaum M; Guerrero LJ; Miller R; DeWane G; Solomaha E; Marks JD; Cohn SL
Oncotarget; 2016 Nov; 7(47):77696-77706. PubMed ID: 27776337
[TBL] [Abstract][Full Text] [Related]
15. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
16. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
17. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
[TBL] [Abstract][Full Text] [Related]
18. Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.
Wu HB; Wang Z; Wang QS; Han YJ; Wang M; Zhou WL; Li HS
PLoS One; 2015; 10(9):e0137676. PubMed ID: 26398657
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells.
Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F
Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659
[TBL] [Abstract][Full Text] [Related]
20. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]